RIVERMARK MEDICAL CLOSES $30 MILLION SERIES C FINANCING TO ADVANCE DEVELOPMENT OF FLOSTENT™ SYSTEM FOR BENIGN PROSTATIC HYPERPLASIA ...Middle East

PR Newswire - News
Novel technology aims to provide immediate relief for patients while seamlessly integrating into routine urological visits MILWAUKEE, Oct. 10, 2024 /PRNewswire/ -- Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), today announced the close...

Hence then, the article about rivermark medical closes 30 million series c financing to advance development of flostent system for benign prostatic hyperplasia was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RIVERMARK MEDICAL CLOSES $30 MILLION SERIES C FINANCING TO ADVANCE DEVELOPMENT OF FLOSTENT™ SYSTEM FOR BENIGN PROSTATIC HYPERPLASIA )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News